MedTrace Logo

StatStrip A Glucose/Creatinine Meter System Lay User Study Evaluation

NCT05144971 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2022-09-28

No results posted yet for this study

Summary

The primary objective of this study is to assess the performance of the Nova StatStrip A Glucose/Creatinine Meter System in the hands of the subject (lay user) and compare the result to an accepted Glucose/Creatinine reference method in the hands of a trained technician.

Conditions

  • Diabete Mellitus
  • CKD
  • ESRD

Interventions

DIAGNOSTIC_TEST

Glucose, Creatinine

Compare diagnostic tests to reference methods

Sponsors & Collaborators

  • Excellence Medical and Research

    collaborator UNKNOWN

  • Nova Biomedical

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-28
Primary Completion
2021-12-03
Completion
2021-12-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05144971 on ClinicalTrials.gov